Global Flow Cytometry Market
Global flow cytometry market is expected to reach USD 13,737,284.12 thousand by 2031 from USD 5,784,657.55 thousand in 2023, growing with a CAGR of 11.51% in the forecast period of 2024 to 2031.
Market Segmentation
Global Flow Cytometry Market, By Product (Flow Cytometry Instruments, Reagents and Consumables, Software, Accessories, and Services), Technology (Cell-Based Flow Cytometry and Bead-Based Flow Cytometry), Application (Research Applications, Clinical Applications, and Industrial Applications), End User (Academic & Research Institutes, Hospitals, Pharmaceutical & Biotechnology Companies, Clinical Testing Laboratories, Blood Banks, and Others), Distribution Channel (Retail Sales and Direct Tenders), Country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Netherland, Switzerland, Turkey, Belgium, rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, rest of Asia-Pacific, Brazil, Argentina, rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt and rest of Middle East and Africa) - Industry Trends and Forecast to 2031
Overview of Global Flow Cytometry Market Dynamics
Drivers
• Rising prevalence of chronic diseases
• Increasing application of cytometry instruments
• Increase in use of flow cytometry in drug discovery
• Growth in stem cell research and acquisition of recombination of DNA technologies
Restraints
• High cost of flow cytometry instruments
• Limitations of flow cytometry
• Lack of skilled professionals
Opportunities
• Increase in adoption of flow cytometry techniques in research and academia
• Development in pharmaceutical and biotechnology industries
• Strategic initiatives by market players
• Developing a pipeline of stem cell research
Challenges
• Difficulty in development and validation of flow cytometry assays
• Complexities related to reagent development
Market Players
The key market players operating in the global flow cytometry market are listed below: • Sysmex Corporation
• Agilent Technologies, Inc.
• BD
• Bio-Rad Laboratories, Inc.
• Beckman Coulter, Inc.
• Sony Biotechnology Inc.
• Apogee Flow Systems Ltd.
• Cytek Biosciences
• BIOMÉRIEUX
• Merck KGaA
• Elabscience Bionovation Inc.
• Miltenyi Biotec
• Takara Bio Inc.
• Thermo Fisher Scientific Inc.
• Q2 Solutions
• CellKraft Biotech Pvt. Ltd.
• Sartorius AG
• NeoGenomics Laboratories
• Cell Signaling Technology, Inc.
• CytoBuoy
• ORFLO Technologies
• IKEDA SCIENTIFIC Co., Ltd.
• BioLegend, Inc.
• Cohorent Corp.
• Union Biometrica, Inc.
• Cytonome/ST, LLC
• Stratedigm, Inc
• NanoCellect Biomedical
• BennuBio Inc.,
• Nexcelom Bioscience LLC
• On-chip Biotechnologies Co., Ltd. Corporation
• Enzo Biochem Inc
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.